#USA #St. Louis #Particle Dynamics #Codis #EUROAPI

Codis Launches as a Global Leader in CDMO Services

On October 14, 2025, Codis officially announced its arrival as a prominent player in the contract development and manufacturing organization (CDMO) landscape, specializing in commercial-scale spray drying, amorphous solid dispersions (ASD), and particle engineering technologies. This newly established firm is a product of the integration of Particle Dynamics and the Haverhill, UK facility that was previously part of EUROAPI. With this merger, Codis aims to redefine the standards of quality and innovation within the pharmaceutical industry.

The Codis Formation

With a footprint of 40,000 m² that spans facilities in St. Louis, Missouri, Seymour, Indiana, and Haverhill, Codis showcases one of the largest commercial spray drying operations globally. The brand not only fuses extensive regulatory expertise but also boasts a manufacturing capacity that stands at over 5,000 metric tons per year. This positions Codis as a significant contributor to the ever-evolving pharmaceutical sector, ensuring consistent and quality output.

Nicolas Fortin, the CEO of Codis, expressed enthusiasm about the company’s potential to propel pharmaceutical innovation. He mentioned, "Codis is built on a foundation of scale, quality, and global reach," emphasizing that their commitment to excellence is unparalleled in the CDMO market. Codis is already approved by six international regulatory agencies, boasting a robust 30-year track record that assures clients of compliance and reliability.

Key Capabilities and Services

Codis offers not only spray drying but also specializes in aqueous and solvent-based techniques, making it a versatile partner for pharmaceutical developers. The company caters to a diverse clientele, with approximately 30 products supplied to more than 50 pharmaceutical customers around the world. The facility in Haverhill is particularly noteworthy, as it has been one of the top manufacturers of the medication Sevelamer, demonstrating its capacity for delivering high-quality, globally recognized products.

In addition to its physical assets, Codis prides itself on its dedication to problem-solving and partnership with global pharmaceutical innovators. The name 'Codis' itself, derived from the Latin term for 'law' or 'system,' underlines their commitment to compliance and systematic excellence in all endeavors.

Looking to the Future

As the global demand for pharmaceutical solutions continues to rise, the emergence of Codis could not be more timely. The integration of advanced technologies in particle engineering and spray drying stands to alleviate some persistent challenges in drug development and manufacturing. By capitalizing on years of experience and expertise, Codis not only assures quality but also enhances efficiency in bringing new therapies to market.

Investing in a future where pharmaceutical redistribution is seamless, Codis represents a reliable solution for manufacturers seeking assistance in the increasingly complex landscape of drug development.

About Codis

Codis is dedicated to advancing the fields of pharmaceutical and consumer health through commercial spray drying and particle engineering. With a focus on environmental sustainability and compliance to regulations, they offer a blend of both capacity and innovation, making them a partner of choice for some of the most recognized names in global pharmaceuticals.

To learn more about Codis and its offerings, visit www.codis.com.